# Hepavec Aktiengesellschaft Für Gentherapie

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hepavec-aktiengesellschaft-fur-gentherapie

- Industry: Pharmaceuticals
- Headquarters: Berlin, Germany
- Total disclosed funding: $4.4M
- Latest round: Series A (May 8, 2000)
- Investors on record: 5

## About

Founded in 1998 and based in Berlin, Germany, Hepavec Aktiengesellschaft Für Gentherapie researches and develops novel treatments for malignant and genetic liver diseases.

## Funding rounds

- Series A, May 8, 2000, $4.4M — AlpInvest Partners, TVM Capital Life Science, DKA Capital, Industrie Management Holding, KB Lux Venture Capital

## Investors

- AlpInvest Partners — Series A
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A
- DKA Capital (https://capitalatlas.ai/funds/dka-capital) — Series A
- Industrie Management Holding (https://capitalatlas.ai/funds/industrie-management-holding) — Series A
- KB Lux Venture Capital — Series A